162 related articles for article (PubMed ID: 11224748)
21. Lymphography as a diagnostic aid in urology.
Brillenburg Wurth GH; Bakker NJ; Tjabbes D
Arch Chir Neerl; 1967; 19(3):233-50. PubMed ID: 5212324
[No Abstract] [Full Text] [Related]
22. Positron emission tomography for prostate, bladder, and renal cancer.
Schöder H; Larson SM
Semin Nucl Med; 2004 Oct; 34(4):274-92. PubMed ID: 15493005
[TBL] [Abstract][Full Text] [Related]
23. Recent developments in urologic oncology: positron emission tomography molecular imaging.
Bouchelouche K; Oehr P
Curr Opin Oncol; 2008 May; 20(3):321-6. PubMed ID: 18391633
[TBL] [Abstract][Full Text] [Related]
24. [Importance of the method of scanning the kidneys in oncologic urology].
Khady-Khodzhaev AG
Vopr Onkol; 1974; 20(4):34-8. PubMed ID: 4439813
[No Abstract] [Full Text] [Related]
25. [Recommendation for clinical practice: use of PET-FDG in cancer of the kidney, prostate, testicles, and the urinary bladder].
Bourguet P; Planchamp F; Montravers F; Vincendeau S; Courbon F; Edeline V; Helal BO; Rossi D; Villers A; ; ; ; ; ; ; ;
Bull Cancer; 2006 Dec; 93(12):1228-32. PubMed ID: 17191352
[No Abstract] [Full Text] [Related]
26. Positron emission tomography (PET) in the urooncological evaluation of the small pelvis.
Machtens S; Serth J; Meyer A; Kleinhorst C; Ommer KJ; Herbst U; Kieruij M; Boerner AR
World J Urol; 2007 Aug; 25(4):341-9. PubMed ID: 17624533
[TBL] [Abstract][Full Text] [Related]
27. Positron Emission Tomography and Computer Tomography (PET/CT) in Prostate, Bladder, and Testicular Cancers.
Zouhair A; Ozsahin M; Schaffer M; Albrecht S; Camus F; Jichlinski P; Mirimanoff RO; Bischof Delaloye A; Meuwly JY; Prior JO
Curr Med Chem; 2010; 17(23):2492-502. PubMed ID: 20491646
[TBL] [Abstract][Full Text] [Related]
28. Emerging technologies in uroradiologic imaging.
Janzen NK; Laifer-Narin S; Han KR; Seltzer M; Thomas MA; Pantuck AJ; Belldegrun AS
Urol Oncol; 2003; 21(5):317-26. PubMed ID: 14670537
[TBL] [Abstract][Full Text] [Related]
29. [2006 technology monitoring report: clinical practice guideline: use of FDG-PET in kidney, prostate, testis and bladder cancers].
Bourguet P; Planchamp F; Montravers F; Vincendeau S; ;
Prog Urol; 2007 Apr; 17(2):172-5. PubMed ID: 17489312
[No Abstract] [Full Text] [Related]
30. Multidetector computed tomography urography (MDCTU) for diagnosing urothelial malignancy.
Anderson EM; Murphy R; Rennie AT; Cowan NC
Clin Radiol; 2007 Apr; 62(4):324-32. PubMed ID: 17331825
[TBL] [Abstract][Full Text] [Related]
31. Genitourinary involvement of lymphomas on FDG-PET.
Naik N; Lin M; Lin P
Br J Radiol; 2018 Jun; 91(1086):20170273. PubMed ID: 29322833
[TBL] [Abstract][Full Text] [Related]
32. [Positron emission tomography. Introduction of a new procedure in diagnosis of urologic tumors and initial clinical results].
Bachor R; Kocher F; Gropengiesser F; Reske SN; Hautmann RE
Urologe A; 1995 Mar; 34(2):138-42. PubMed ID: 7754585
[TBL] [Abstract][Full Text] [Related]
33. Contribution of 11C-choline positron emission tomography/computerized tomography to preoperative staging of advanced transitional cell carcinoma.
Gofrit ON; Mishani E; Orevi M; Klein M; Freedman N; Pode D; Shapiro A; Katz R; Libson E; Chisin R
J Urol; 2006 Sep; 176(3):940-4; discussion 944. PubMed ID: 16890661
[TBL] [Abstract][Full Text] [Related]
34. PET/Computed Tomography in Renal, Bladder, and Testicular Cancer.
Bouchelouche K; Choyke PL
PET Clin; 2015 Jul; 10(3):361-74. PubMed ID: 26099672
[TBL] [Abstract][Full Text] [Related]
35. The clinical advances of fluorine-2-D-deoxyglucose--positron emission tomography/computed tomography in urological cancers.
Avril N; Dambha F; Murray I; Shamash J; Powles T; Sahdev A
Int J Urol; 2010 Jun; 17(6):501-11. PubMed ID: 20370848
[TBL] [Abstract][Full Text] [Related]
36. PET-imaging in tumors of the reproductive trac.
Reinhardt MJ; Matthies A; Biersack HJ
Q J Nucl Med; 2002 Jun; 46(2):105-12. PubMed ID: 12114873
[TBL] [Abstract][Full Text] [Related]
37. PET in the management of urologic malignancies.
Kumar R; Zhuang H; Alavi A
Radiol Clin North Am; 2004 Nov; 42(6):1141-53, ix. PubMed ID: 15488563
[TBL] [Abstract][Full Text] [Related]
38. Evolving role of positron emission tomography (PET) in urological malignancy.
Mafeld S; Vasdev N; Patel A; Ali T; Lane T; Boustead G; Thorpe AC; Adshead JM; Haslam P
BJU Int; 2015 Oct; 116(4):538-45. PubMed ID: 25410715
[TBL] [Abstract][Full Text] [Related]
39. [The value of lymphography in testicular, bladder and kidney tumors].
Buhtz C; Richter A
Z Urol Nephrol; 1984 Jun; 77(6):321-8. PubMed ID: 6475333
[TBL] [Abstract][Full Text] [Related]
40. Advances in Imaging in Prostate and Bladder Cancer.
Srivastava A; Douglass LM; Chernyak V; Watts KL
Curr Urol Rep; 2017 Sep; 18(9):69. PubMed ID: 28718164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]